BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soares-Weiser K, Bergman H, Henschke N, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2019;2019. [PMID: 31684685 DOI: 10.1002/14651858.CD008521.pub5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Meki CD, Ncube EJ, Voyi K. Community-level interventions for mitigating the risk of waterborne diarrheal diseases: a systematic review. Syst Rev 2022;11. [DOI: 10.1186/s13643-022-01947-y] [Reference Citation Analysis]
2 Amit LN, Mori D, John JL, Chin AZ, Mosiun AK, Jeffree MS, Ahmed K. Emergence of equine-like G3 strains as the dominant rotavirus among children under five with diarrhea in Sabah, Malaysia  during 2018-2019. PLoS One 2021;16:e0254784. [PMID: 34320003 DOI: 10.1371/journal.pone.0254784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Derso T, Kebede A, Wolde HF, Atnafu A, Dellie E. Rotavirus Vaccine Coverage and Associated Factors Among a Rural Population: Findings from a Primary Health-Care Project in Two Northwest Ethiopia Districts. Pediatric Health Med Ther 2020;11:429-35. [PMID: 33117058 DOI: 10.2147/PHMT.S276037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ugboko HU, Nwinyi OC, Oranusi SU, Oyewale JO. Childhood diarrhoeal diseases in developing countries. Heliyon 2020;6:e03690. [PMID: 32322707 DOI: 10.1016/j.heliyon.2020.e03690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
5 Posovszky C, Buderus S, Classen M, Lawrenz B, Keller KM, Koletzko S. Acute Infectious Gastroenteritis in Infancy and Childhood. Dtsch Arztebl Int 2020;117:615-24. [PMID: 33263539 DOI: 10.3238/arztebl.2020.0615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Garziano M, Utyro O, Poliseno M, Santantonio TA, Saulle I, Strizzi S, Lo Caputo S, Clerici M, Introini A, Biasin M. Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees. Front Immunol 2022;13:820250. [DOI: 10.3389/fimmu.2022.820250] [Reference Citation Analysis]
7 Besnier E, Thomson K, Stonkute D, Mohammad T, Akhter N, Todd A, Rom Jensen M, Kilvik A, Bambra C. Which public health interventions are effective in reducing morbidity, mortality and health inequalities from infectious diseases amongst children in low- and middle-income countries (LMICs): An umbrella review. PLoS One 2021;16:e0251905. [PMID: 34111134 DOI: 10.1371/journal.pone.0251905] [Reference Citation Analysis]
8 Oberle D, Hoffelner M, Pavel J, Mentzer D, Barth I, Drechsel-Bäuerle U, Keller-Stanislawski B. Retrospective multicenter matched case-control study on the risk factors for intussusception in infants less than 1 year of age with a special focus on rotavirus vaccines - the German Intussusception Study. Hum Vaccin Immunother 2020;16:2481-94. [PMID: 32271647 DOI: 10.1080/21645515.2020.1726679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Health 2020;8:e1195-202. [PMID: 32827481 DOI: 10.1016/S2214-109X(20)30262-X] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
10 Uprety T, Wang D, Li F. Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development. Arch Virol 2021;166:2369-86. [PMID: 34216267 DOI: 10.1007/s00705-021-05142-7] [Reference Citation Analysis]
11 Otero CE, Langel SN, Blasi M, Permar SR. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS Pathog 2020;16:e1009010. [PMID: 33211756 DOI: 10.1371/journal.ppat.1009010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kaslow DC. Force of infection: a determinant of vaccine efficacy? NPJ Vaccines 2021;6:51. [PMID: 33846340 DOI: 10.1038/s41541-021-00316-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]